DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Curry N, Albayrak C, Escobar M. et al.
Once-weekly prophylaxis with glycoPEGylated recombinant factor VIII (N8-GP) in severe haemophilia A: safety and efficacy results from pathfinder 2 (randomized phase III trial).
Haemophilia 2019;
25 (03) 373-381
We do not assume any responsibility for the contents of the web pages of other providers.